CLOUD DIAGNOSTICS AWARD WINNING DISRUPTOR IN VIRTUAL CARE AND THE MEDICAL METAVERSE - Capital Event Management Ltd.
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
TSXV:CDX | OTCQB:CDXFF CLOUD DIAGNOSTICS ® AWARD WINNING DISRUPTOR IN VIRTUAL CARE AND THE MEDICAL METAVERSE INVESTOR PRESENTATION - February 14, 2022 clouddx.com
D I SC L A I M E R TSXV:CDX | OTCQB:CDXFF
CONFIDENTIALITY; NOTE REGARDING FORWARD-LOOKING STATEMENTS
This presentation (the “Presentation”) of Cloud DX Inc. (“Cloud DX” or the “Corporation”) and competitors; the nature, timing and price of the Offering; and the use of proceeds of the offering. products; our ability to remain competitive as other better financed competitors develop and
the material contained herein are strictly confidential and are not to be disclosed to the public, Such statements and information are based on numerous assumptions regarding present and release competitive products; changes in laws; regulatory uncertainties; a substantial delay
reproduced or distributed to any other person or published, in whole or part, for any purpose future business strategies and the environment in which the Corporation will operate in the or denial in the approval by the FDA or other negative regulatory processes or limitations on
whatsoever. This Presentation is for information purposes of the recipient only and shall not future, including: the demand for our products and services, including from existing customers; Cloud DX’s abilities to test or market its products consistent with their intended uses, could result
constitute an offer to sell, or a solicitation or an offer to buy, any securities of the Corporation in our ability to upgrade technology and develop technological improvements; anticipated costs in a material adverse effect on Cloud DX’s business plans, results of operations, and financial
any jurisdiction where such offer, solicitation or sale would be unlawful. The information contained and our ability to achieve goals; our ability to attract and retain experienced personnel and conditions; our dependence on our intellectual property rights; our ability to successfully maintain
herein is subject to change without notice and is based on publicly available information, internally executive leadership; our ability to anticipate the future needs of our customers; our ability to and enforce our intellectual property rights and defend third-party claims of infringement of their
developed data and other sources. Where any opinion or belief is expressed in this Presentation, maintain supplier and customer relationships; sales opportunities available to us; our ability to intellectual property rights; the impact of intellectual property litigation that could materially
it is based on the assumptions and limitations mentioned herein and is an expression of present increase revenue by increasing our sales and marketing expenses; the creditworthiness of our and adversely affect our business; our failure to develop new and innovative products; our
opinion or belief only. This Presentation should not be construed as legal, financial or tax advice to contract counterparties; that our products and services will remain competitive by outperforming reliance on novel technologies which presently include investments in innovative medical
any individual, as each individual’s circumstances are different. The recipient of this Presentation standard devices of our competitors; our ability to obtain all necessary regulatory approvals technologies; the impact of technological changes on our products and industry; our failure to
should consult with its own professional advisors regarding its particular circumstances. Unless and patent and intellectual property protections for our products and services; the continued
develop technological upgrades and new technologies; the impact of product liability claims
defined herein, all capitalized words shall have the meanings ascribed to them elsewhere in the integration of our products and services with leading third-party devices, operating systems,
that could materially and adversely affect our business; our ability to attract, retain and motivate
Presentation. apps, web browsers and API integrations; the continued availability of government funding,
qualified personnel and key employees; failure of counter-parties to perform their contractual
This Presentation contains certain forward-looking statements and forward-looking information grants and private insurance coverage to subsidize products and services in the RPM industry,
obligations; business, economic and market conditions; demand and pricing for our products;
(collectively referred to herein as “forward-looking statements”) within the meaning of including our products and services; our ability to access future capital investment; the size
whether Cloud DX can continue as a going concern will be dependent on raising additional
applicable securities laws. All statements other than statements of historical fact are forward- of the Offering; the completion of the Offering; and the use of proceeds therefrom; and to the
capital and ultimately reaching profitability; our requirement to raise additional financing to fund
looking statements. Forward-looking statements are often, but not always, identified by the extent needed, that additional financing is available. Although we believe that the assumptions
operating losses and among other things, continue product development and testing, pursue
use of words such as “anticipate”, “achieve”, “could”, “believe”, “plan”, “intend”, “objective”, underlying these statements are reasonable, they may prove to be incorrect. Given these risks,
regulatory approvals, develop sufficient marketing and distribution networks, create a sufficient
“continuous”, “ongoing”, “estimate”, “outlook”, “expect”, “may”, “will”, “project”, “should” uncertainties and assumptions, you should not place undue reliance on these forward-looking
network of trained doctors capable of using our products, purchase fixed assets and pay salaries
or similar words, including negatives thereof, suggesting future outcomes. Forward-looking statements.
and other operating expenses and expand manufacturing capabilities and create inventory; the
statements in this Presentation may include, among other things, statements about: our Forward-looking statements in this Presentation are subject to known and unknown risks,
broad discretion of the board of directors of Cloud DX to apply proceeds from financings; and the
business strategy and performance expectations, including sales growth expectations; general uncertainties and other important factors that may cause the actual results to be materially
return of capital and the realization of gains, if any, from an investment in Cloud DX will occur
expectations regarding the growth of, trends in and projected value of the remote patient different from those expressed or implied by such forward-looking statements, including but
only upon sale, licensing or other significant liquidity transaction, or the Corporation obtaining
monitoring (“RPM”) market; our revenue and revenue growth models; expected opportunities not limited to: the fact that Cloud DX is an early stage company with a short operating history
meaningful profitability.
for market share penetration and our expected sales pipeline; the expected long term impacts and may not actually achieve its plans, projections, or expectations; the fact that Cloud DX is
of COVID-19 on demand in the RPM market; the availability of government funding, grants and not expected to generate profit in the foreseeable future and will continue to incur significant Except as required by law, we undertake no obligation to update or revise any forward-looking
private insurance coverage to subsidize products and services in the RPM industry, including our operating losses while it continues further research and development, pursues regulatory statements, whether as a result of new information, future event or otherwise, after the date on
products and services; our plans for future products and services, and for enhancements to our approvals and commercialization of its products and further implements its business plans; the which the statements are made or to reflect the occurrence of unanticipated events. Neither we
existing products and services; our future intellectual property; expectations regarding key areas business model and certain key development stage products are unproven and may never be nor any of our representatives make any representation or warranty, express or implied, as to the
of growth in the industry; our future growth strategy and growth rate; expectations regarding successful or generate any significant revenues or profits; our ability to manage our operating accuracy, sufficiency or completeness of the information in this Presentation. Neither we nor any
future revenue, revenue growth, profit and loss, cost of goods sold, gross margin, selling, expenses, which may adversely affect our financial condition; research to date of certain of our representatives shall have any liability whatsoever, under contract, tort, trust or otherwise,
general and administrative expenses, other income and expenses and EBITDA, our competitive products of Cloud DX is in the early stages with limited clinical data and no assurance can be to you or any person resulting from the use of the information in this Presentation by you or any of
market and the expected revenue growth, future revenue, EBITDA and margins for certain of our given that the preliminary data will ultimately be validated or lead to successful commercial your representatives or for omissions from the information in this Presentation.
Unless otherwise noted, all figures are in US Dollars.
clouddx.com 2
W H AT W E DO TSXV:CDX | OTCQB:CDXFF
EXCLUSIVE PARTNERSHIP
EQUITABLE LIFE FAC TS1
February 14, 2022 Founded in 1920
Equitable Life® has chosen Cloud DX to provide RPM One of Canada’s largest
services to critical illness insurance clients. Eligible Mutual Insurers
claimants will receive a Cloud DX Connected Health™ kit
and monitoring services, fully covered for six months, $6 billion in assets under
and can opt to continue with the service thereafter administration
for a monthly fee. Equitable Life is the first insurer in
Canada to offer health and medical monitoring through Ranked #1 in Canada
Cloud DX to all its individual life critical illness clients. in 2019 survey. 2
1. www.equitable.ca/en/who-we-are; 2. LIMRA CxP Customer Experience Benchmarking Program, Life Insurance In-Force Experience.
clouddx.com 3
WHO WE ARE TSXV:CDX | OTCQB:CDXFF
THE COMPANY
Major Commercial Partnerships - contracts with Vital
Founded 2014
Aire Canada (division of Air Liquide), homecare leader
CBI Health and most recently exclusive partnerships Certifications ISO 13485
with Medtronic Canada, a division of Medtronic Health Canada MDL
(NYSE:MDT) and Equitable Life Insurance Canada.
FDA HEALTH
CANADA Health Canada MDEL
CLEARED LICENSED
FDA Registration
Competitive - signed multi-year agreements with
Canadian Provincial & Territorial Governments, over FDA 510(k)
20 contracts to date across Canada and a growing FDA MDDS
base of US contracts with clinics and hospitals.
Offices Kitchener, ON (CDN HQ & Tech Centre)
Award Winning - with over a dozen competitive awards Brooklyn, NY (US HQ)
for new technologies including Canada’s first ‘XPRIZE’, an
Auditors MNP LLP TÜV SÜD
‘Edison Award’ and Fast Company ‘World Changing Idea’. Just
named one of Canada’s top 10 most innovative companies Legal Dentons
as a Canadian Business magazine 2022 New Innovator.
clouddx.com 4
WHO WE ARE TSXV:CDX | OTCQB:CDXFF
BOARD OF DIRECTORS
Robert Kaul Dr Sonny Kohli Michele Middlemore
Former CEO & director of Biosign Former director of Biosign; Former Cloud DX interim-CFO,
Technologies Inc. (TSXV:BIO) currently enrolled at ICD-Rotman Chartered Accountant; former
Directors Education Program VP of Hospice Toronto
Brad Miller Dr Constantine Zachos William Charnetski
Founder & CEO of Advantec Practicing physician; currently director Former Ontario Health Innovation
Global; former director of ParkIt at Exerkine Corporation, Toronto, ON Strategist; currently EVP at PointClickCare;
Enterprise Inc. (TSXV:PKT) former director at Waterfront Toronto
Chairman of the Board Lead Independent Director Audit Committee Chair Audit Committee Member Compensation Committee Chair Compensation Committee Member
clouddx.com 5
W H AT W E DO TSXV:CDX | OTCQB:CDXFF
OUR PROVEN VIRTUAL CARE PLATFORM
Cloud DX goes beyond standard telemedicine offerings through
unique data collection hardware, software & key differentiators
VCaaP
“Virtual Care as a Platform”
• Remote patient monitoring
• Clinician dashboards
• Telemedicine visits
• Text messaging
• Symptom tracking
• Wound care
• Patient engagement tools
clouddx.com 6
W H AT W E DO TSXV:CDX | OTCQB:CDXFF
OUR PROVEN VIRTUAL CARE PLATFORM
Cloud DX goes beyond standard telemedicine offerings through unique
data collection hardware, software & key differentiators
eXtended Reality
Connected Health NEW DIVISION “CLOUD XR”
Connected Health App and Bringing the Medical Metaverse to life
wireless medical devices with fully patented, award-winning
Virtual Clinical Assistant™ platform
including VITALITI™ continuous vital
sign monitor, 3D holographic user
interface and EMR integration.
Clinician Portal
AWARDS PA RTNER FUNDING FROM
Clinician Portal with Notifications
and EMR Integration
NOV2017
PRIX DU
CRSNG
20
21
NSERC
PRIZES
NSERC 20 PRIX
DU
PRIZES 21 CRSNG
clouddx.com 7
WHY WE WIN TSXV:CDX | OTCQB:CDXFF INTELLECTUAL PROPERTY PROTECTION • 6 granted patents • 3 licensed patents • 5+ pending patents • 3 registered trademarks clouddx.com 8
W H AT W E DO TSXV:CDX | OTCQB:CDXFF
VALUE PROPOSITIONS
Why clinicans and patients are both embracing virtual care and RPM
$ $ $
PATIENTS PROVIDERS PAYERS
Go home sooner from Eliminate the million+ post- Save money with much
hospital after surgery COVID surgical backlog more efficient care
Avoid medication errors and Avoid the ER and/or hospital Make more money
experience less severe pain admission for CHF / COPD (US providers)
COPD - Chronic Obstructive Pulmonary Disease; CHF - Congestive Heart Failure
clouddx.com 9
W H AT W E DO TSXV:CDX | OTCQB:CDXFF
MARKETS WE ADDRESS
C H R O N I C PAT I E N T S POSTPONED SURGERIES S U R G I C A L CO M PL I C AT I O N S
5+ Canadians over 35 Globally every year,
who suffer from
MILLION COPD & CHF1,2 America for Adults +45 yrs: 7
>2,000,000
5
Americans 100,000,000 major surgeries
62+ who qualify for 29,000,000 complications (29%)
MILLION reimbursed RPM3 Canada
7,000,000 readmissions (7%)
>560,000
6
1 in 3
Adults suffer
multiple chronic 1,500,000
conditions 4 deaths (1.5%)
1. Health Infobase Canada COPD-blog 5. McKinsey
2. Canada Public Health Diseases Conditions Fact Sheet 6. CIHI.ca
3. CMS.gov/Medicare 7. Spence J, et al.. Association between complications and death
4. Global burden of multiple chronic conditions; PubMed.10.2019 within 30 days after noncardiac surgery. CMAJ July 29, 2019.
clouddx.com 10W H AT W E DO TSXV:CDX | OTCQB:CDXFF
RPM PATIENT GROWTH 70.6
Remote Patient Monitoring
60.6 (RPM) is expected to grow quickly in the near term
53.1
NEW
45.1
PATIENTS US REMOTE PATIENT MONITORING USERS, 2020-2025
70.6
Insider Intelligence estimates 70.6
70.6
60.6
million US patients will use RPM
tools by 2025 - over 100% growth 53.1
from 29.1 million patients in 2020.1 45.1
39.3
17.8% 16.4%
14.6% 14.2% 29.1
2022 2023 2024 2025
Remote patient
monitoring users 34.4% 35.3%
(millions)
% Change 17.8% 16.4%
14.6% 14.2%
16.4%
1. https://www.insiderintelligence.com/
2020 2021 2022 2023 2024 2025
insights/remote-patient-monitoring-
2025industry-explained/. August 2021
clouddx.com 11W H AT W E DO TSXV:CDX | OTCQB:CDXFF
GO TO MARKET - CANADA
Hospitals Governments Partnerships
Cloud DX RPM is deployed by a growing Provincial and Territorial Governments Cloud DX has partnership agreements
list of hospitals across Canada for contract Cloud DX directly and with Canadian market leaders including
chronic disease management, post- purchase RPM services for the entire Medtronic Canada, CBI Health, Lung
surgical monitoring and palliative care. province/territory. In 2021 Cloud DX Health Ontario, Vital Aire Canada (a
achieved Verified Vendor status with division of Air Liquide) and Equitable Life.
Canada Health Infoway and Ontario
MD, speeding up procurement.
University
of Alberta
Hospital
Edmonton
Western Canadian
JURAVINSKI Provincial Health
HOSPITAL Authority 1
1. Authority name redacted under terms of agreement
clouddx.com 12W H AT W E DO TSXV:CDX | OTCQB:CDXFF
GO TO MARKET - USA
Hospitals Clinics Patient-First™
As in Canada, Cloud DX Connected Health Cloud DX signs multi-year contracts Cloud DX’s unique program to enroll
is deployed by US Hospitals for COVID with US clinics to deploy Connected the neediest patients in reimbursed
outpatient care and chronic disease Health for reimbursed RPM. One key RPM programs, matched to specialist
management, notably at the Blessing partner is Maxwell Telecare, a ‘doctor- physicians like Home Medical. Our Prizm
Health system in Illinois. US Hospitals are on-demand’ provider with physicians Media partnership identifies and educates
a business development focus in 2022. licensed in all 50 States. See recent patients from a database of over 1
announcements of five new Maxwell million US adults with chronic illness.
contracts on 11/30/21 and 01/11/22.
University Geriatrics
& Internal Medicine
Associates LLC
clouddx.com 13W H AT W E DO TSXV:CDX | OTCQB:CDXFF
PATIENTS AVAILABLE
~2,000,000
‘Patients available’ refers to patients that qualify
for remote monitoring under a contract. Access to
available patients is a key growth metric for Cloud
DX. Under contracts announced in 2021 we have
increased our access to patients exponentially.
~1,000,000
RTO
3,700 6,200 31,300
2020 2021 - Q1 2021 - Q2 2021 - Q3 2021 - Q4
clouddx.com 14BUS I N E SS D E V E LO PM E NT TSXV:CDX | OTCQB:CDXFF
REVENUE GROWTH
As the virtual care & digital medicine industry expands exponentially,
our revenues are expected to grow in 3 key areas:
CANADA UNITED STATES GLOBAL
Cloud DX is already a leader in Canadian Cloud DX is increasing US sales activity Further growth expected as announced
RPM with deployments from coast to and expects rapid growth in 2022, driven agreements with Partners move into the
coast to coast. We expect growth in the by new hospital engagements, clinical deployment stage. Partnerships with
form of new government contracts, and in contracts (Maxwell Telecare and others) Medtronic, Vital Aire (Air Liquide) and
particular our integration with Medtronic and in particular the launch of our others showcase that Cloud DX delivers
Canada across all lines of business, Patient-First™ program, addressing up highly differentiated products and services
addressing up to 1 million patients. to 1 million chronic disease patients. that can grow across multiple countries.
University
of Alberta
Hospital AcuScreen CA™
Edmonton
(examples of growth contracts)
clouddx.com 15WHY WE WIN TSXV:CDX | OTCQB:CDXFF
RECOGNITION OF EXCELLENCE
Cloud DX continues to earn competitive awards for cutting-edge innovation
PRIX
WINNER
DU
CRSNG
Co-winner
20
NSERC Synergy
21
Award 2021
NSERC
B OL D EPIC I N N OVATO R AWA R D PRIZES
Awarded Feb 7, 2022
Medical IoT Division
NOV2017
EXPONENTIAL
20 21
MEDICINE
Fastest Growing Private 2019 Startup to Scale 2021 Pandemic 2015 - Winner
Companies Up Award of Excellence Tech Award Startup of the Year
NSERC 20
PRIZES 21
CANADA’S 2018 WORLD VOTED
MOST CHANGING BY AARP
INNOVATIVE IDEAS READERS
COMPANIES FINALIST
2020 COVID-19 Innovation
Challenge Co-Winner
clouddx.com 16I N V E STM E NT DATA TSXV:CDX | OTCQB:CDXFF CAPITAL STRUCTURE Insiders1 agreed (01/17/22) to voluntarily escrow shares of Cloud DX issued to them pursuant to the Corporation’s reverse take over transaction until at least October 31, 2022; additional Exchange restrictions on Insider selling also apply. Please see Cloud DX’s SEDAR profile for more details on Insider sale restrictions. Issued and Outstanding 72,094,396 Fully Diluted 89,978,604 Public Float 48,752,730 Insider %2 34% 1. as defined by the TSXV; 2. approx. insider ownership of issued and outstanding shares at 02/14/22. clouddx.com 17
W H AT W E DO TSXV:CDX | OTCQB:CDXFF
DIFFERENTIATORS
Innovation Satisfaction Partnerships
Cloud DX is unique among RPM providers Patient satisfaction is a key competitive Cloud DX has signed major contracts with
in launching new technology. Recent advantage for Cloud DX. In the US, patient global market leaders after extensive
examples include the VITALITI continuous satisfaction is rewarded with higher vetting and often fierce competition.
non-invasive blood pressure monitor reimbursements from payers, driving Unique IP, deep relationships with
(10/7/21), AcuScreen smartphone cough revenue. In Canada satisfaction scores doctors and outstanding customer
analysis app to detect tuberculosis win new contracts via referrals and high service are differentiators that
(11/3/21), and Cloud XR Virtual Clinical ratings in competitive tenders and RFPs. make Cloud DX a leader in RPM.
Assistant Metaverse application (2/3/22).
Proof: Medtronic contract release
Proof: competitive non-dilutive funding Proof: recently announced survey from (12/1/21), a video of Medtronic VP
(pg 28), published academic research (pg The Ottawa Hospital - 97% satisfied of Partnerships Jessica Rudd here
26), growing patent portfolio (pg 19) and (2/1/22), and published academic studies - and Equitable release (02/14/22).
over a dozen awards for innovation (pg 20). U. Arkansas1 (100% recommended).
XR AcuScreen CA™
1 Evaluating the Use of Mobile Health Technology in Older Adults With Heart Failure: Mixed-Methods Study. Aging.JMIR April 12, 2018
clouddx.com 18H I G H LI G HTS TSXV:CDX | OTCQB:CDXFF
WHY INVEST IN CLOUD DX?
• Digital and virtual health • Published studies show 30% • Exceptional Partners including
care among the world’s fastest of surgical patients go home CBI Health, Medtronic, Air Liquide
growing sectors: projected with medication errors; 14% and now Equitable Life.2
growth of 128% by 2027.1 fewer CDX users experienced
• Management believes that Cloud
severe pain; patients report 97%
• Cloud DX is an award winning DX is a revenue generating
satisfaction in 3rd party survey.
virtual health care innovator: blue sky opportunity.
Tricorder XPRIZE Award; 2021 • Over 2 million patients now
Edison Award, many more. accessible under contracts
executed as of year end 2021.2
• Meeting real needs: 1 in 3
adults has a chronic disease; • Growth is accelerating: 12 new
1 in 6 has a neurological contracts announced
disorder; 29% of surgeries from Nov 1, 2021 to
have serious complications. Feb 14, 2022, including
Hamilton Health Sciences
1. ResearchandMarkets “Remote Patient Monitoring and (2,400 patients).2
Telehealth Markets 12th Edition” April 2021
2. See Cloud DX press releases 9/16/21, 11/10/21, 11/17/21, 11/30/21,
12/01/21, 12/15/21, 12/21/21, 1/11/22, 02/10/22, 02/14/22.
Note: This slide contains forward-looking statements. Please review the disclaimer on pg 2.
clouddx.com 19D I SC L A I M E R TSXV:CDX | OTCQB:CDXFF
Financial Information: Certain financial information included in this document is unaudited. are the property of their respective owners. The Corporation’s use or display of third parties’ The following is a summary of rights of rescission or damages, or both, available to most
There is a material risk that the audited financial results would differ significantly from unaudited trademarks, service marks, trade names or products in this Presentation is not intended to, and purchasers resident in the province of Ontario, New Brunswick, Nova Scotia and Saskatchewan.
financial information presented herein. does not imply, a relationship to Cloud DX or an endorsement or sponsorship by or of Cloud If there is a misrepresentation herein and you are a purchaser under securities legislation in
DX. Solely for convenience, the trademarks, service marks, and trade names referred to in this Ontario, New Brunswick, Nova Scotia or Saskatchewan you have, without regard to whether you
Certain information in this Presentation contain references to non-IFRS measures, such as
Presentation may appear without the ®, ™ or SM symbols, but such references are not intended relied upon the misrepresentation, a statutory right of action for damages, or while still the owner
EBITDA, that do not have standardized meaning under IFRS as prescribed by the International
to indicate, in any way, that the Corporation or the applicable third party that is the owner of any of the securities, for rescission against the Corporation. This statutory right of action is subject
Accounting Standard Board and are therefore unlikely to be comparable to similar measures
such trademark, service mark or trade name, as applicable, will not assert, to the fullest extent to the following: (a) if you elect to exercise the right of action for rescission, you will have no right
presented by other companies. These measures are provided as additional information to
under applicable law, its right or the right of the applicable licensor to the applicable trademark, of action for damages against the Corporation; (b) except with respect to purchasers resident in
complement IFRS measures by providing further understanding of the Corporation’s operations
service mark or trade name. Nova Scotia, no action shall be commenced to enforce a right of action for rescission after 180
from management’s perspective. Non-IFRS measures should not be considered in isolation or as
a substitute for analysis of financial information under IFRS. CAUTIONARY NOTE TO RECIPIENTS IN THE UNITED STATES: THIS PRESENTATION AND THE days from the date of the transaction that gave rise to the cause of action; (b) except with respect
MATERIAL CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF to purchasers resident in Nova Scotia, no action shall be commenced to enforce a right of action
To the extent any forward looking information in this Presentation constitutes future-oriented
AN OFFER TO BUY ANY SECURITIES IN CLOUD DX INC. SUCH AN OFFER AND SOLICITATION MAY for rescission after 180 days from the date of the transaction that gave rise to the cause of action;
financial information and financial outlook information (collectively, “FOFI”) within the meaning
ONLY BE MADE PURSUANT TO A PRIVATE SUBSCRIPTION AGREEMENT AND OTHER APPLICABLE (c) no action shall be commenced to enforce a right of action for damages after the earlier of (i)
of applicable Canadian securities laws, such information is being provided as of the date of this
DOCUMENTS (THE “OPERATIVE DOCUMENTS”), WHICH SHOULD BE READ IN THEIR ENTIRETY. 180 days (with respect to purchasers resident in Ontario) or one year (with respect to purchasers
Presentation and is provided for the purpose of providing information: (i) about management’s
THE STATEMENTS IN THIS PRESENTATION ARE NOT INTENDED TO BE COMPLETE OR FINAL AND resident in Saskatchewan and New Brunswick) after you first had knowledge of the facts giving
current expectations and plans relating to the future; and (ii) to demonstrate the potential
ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO THE OPERATIVE DOCUMENTS. IN THE rise to the cause of action and (ii) three years (with respect to purchasers resident in Ontario)
benefits of the Corporation’s business plans and strategies, and the reader is cautioned that this
EVENT THAT THE DESCRIPTIONS OR THE TERMS DESCRIBED HEREIN ARE INCONSISTENT WITH or six years (with respect to purchasers resident in Saskatchewan and New Brunswick) after
information may not be appropriate for any other purpose and should not place undue reliance
OR CONTRARY TO THE DESCRIPTIONS IN OR THE TERMS OF THE OPERATIVE DOCUMENTS, THE the date of the transaction that gave rise to the cause of action; (d) with respect to purchasers
on such FOFI. As with forward-looking information generally, FOFI are, without limitation, based OPERATIVE DOCUMENTS SHALL GOVERN. THEREFORE ANY RECIPIENT HEREOF SHOULD READ
on the assumptions and subject to certain risks, including without limitation, those set out above resident in Nova Scotia, no action shall be commenced to enforce a right of action for rescission
THE OPERATIVE DOCUMENTS AND SHOULD CONDUCT ITS OWN INDEPENDENT ANALYSIS OF THE or damages after 120 days from the date on which payment for the securities was made by you; (e)
under the heading “Note Regarding Forward-Looking Statements”. The Corporation’s actual DATA REFERRED TO HEREIN.
financial position and results of operations may differ materially from management’s current the Corporation will not be liable if it proves that you purchased the securities with knowledge of
THE SECURITIES DESCRIBED HEREIN HAVE NOT AND WILL NOT BE REGISTERED UNDER THE the misrepresentation; (f) in the case of an action for damages, the Corporation will not be liable
expectations and, as a result, the Corporation’s future revenues, revenue growth, margins,
SECURITIES ACT OF 1933 (THE “SECURITIES ACT”) OR ANY US STATE SECURITIES LAWS OR for all or any portion of the damages that it proves do not represent the depreciation in value of
and EBITDA may differ materially from future-oriented financial information provided in this
UNDER THE SECURITIES LAWS OF CANADA OR ANY OTHER JURISDICTION. EACH PURCHASER IN the securities as a result of the misrepresentations; and (g) in no case will the amount recoverable
Presentation. Such information is presented for illustrative purposes only and may not be an
THE UNITED STATES MUST BE A “QUALIFIED INSTITUTIONAL BUYER” AS DEFINED BY RULE 144A in such action exceed the price at which securities were sold to you. The foregoing is a summary
indication of the Corporation’s actual financial position or results of operations.
UNDER THE SECURITIES ACT OR AN “ACCREDITED INVESTOR” AS DEFINED BY REGULATION D only and is subject to the express provisions of the Securities Act (Ontario), the Securities Act
Third Party Information: This Presentation also contains or references certain market, industry UNDER THE SECURITIES ACT. (New Brunswick), the Securities Act (Nova Scotia) and the Securities Act (Saskatchewan), and
and peer group data which is based upon information from independent industry publications,
Canadian Investor Notice; Statutory Rights of Action: In certain circumstances, purchasers the rules, regulations and other instruments thereunder, and reference is made to the complete
market research, analyst reports and surveys and other publicly available sources. Although
resident in certain provinces of Canada, are provided with a remedy of rescission or damages, text of such provisions contained therein. Such provisions may contain limitations and statutory
the Corporation believes these publications and reports to be reliable, it has not independently
or both, in addition to any other right they may have at law, where an offering memorandum defences on which the Corporation may rely.
verified any of the data or other statistical information contained therein, nor has it ascertained
(such as this Presentation) and any amendment to it contains a misrepresentation. Where used
or validated the underlying economic or other assumptions relied thereon by these sources and In Manitoba, the Securities Act (Manitoba), in Newfoundland and Labrador, the Securities Act
herein, “misrepresentation” means an untrue statement of a material fact or an omission to
cannot, and does not, provide any representation or assurance as to the accuracy or completeness (Newfoundland and Labrador), in Prince Edward Island, the Securities Act (PEI), in Yukon, the
state a material fact that is required to be stated or that is necessary to make any statement not
of the information or data, or the appropriateness of the information or data for any particular Securities Act (Yukon), in Nunavut, the Securities Act (Nunavut) and in the Northwest Territories,
misleading in light of the circumstances in which it was made. These remedies, or notice with
analytical purpose, and accordingly, disclaims any liability in relation to such information and the Securities Act (Northwest Territories) provide a statutory right of action for damages
respect to these remedies, must be exercised or delivered, as the case may be, by the purchaser
data. The Corporation has no intention and undertakes no obligation to update or revise any such or rescission to purchasers resident in Manitoba, Newfoundland, PEI, Yukon, Nunavut, and
within the time limits prescribed by applicable securities legislation. The following summary is
information or data, whether as a result of new information, future events or otherwise, except subject to the express provisions of the applicable securities laws, regulations and rules, and Northwest Territories respectively, in circumstances where this Presentation or an amendment
as required by law. reference is made thereto for the complete text of such provisions. Such provisions may contain hereto contains a misrepresentation, which rights are similar, but not identical, to the rights
Trademarks and Trade Names: The Corporation owns or has rights to various trademarks, limitations and statutory defences not described here on which the Corporation and other available to Ontario purchasers.
service marks and trade names that it uses in connection with the operation of its business. This applicable parties may rely. Purchasers should refer to the applicable provisions of the securities The statutory right of action described above is in addition to and without derogation from any
Presentation also contains trademarks, service marks and trade names of third parties, which legislation of their provinces for the particulars of these rights or consult with a legal adviser. other right or remedy at law.
clouddx.com 20TSXV:CDX | OTCQB:CDXFF
CDN HEADQUARTERS
K in tN
gS ri aS
tW
Vi c to
100 - 72 Victoria St South
72 Victoria St S
N Ch
K in Kitchener, ON N2G 4Y9
St ar gS
ia tE
V ic
t or
W
les
St Hw
888-543-0944
St E y#
en
e 8 info@clouddx.com
clouddx.com
Qu Pk wy
s toga
Cone
FD R D ri ve US HEADQUARTERS
Ma
nh
at t
Br
20 Jay Street, Unit 834
an
oo
kl
Bri
Contact Investor Relations
20 Jay St
yn
Brooklyn, New York 11201
d ge
Br
id
888-543-0944
ge
investor.relations@clouddx.com info@clouddx.com
Brooklyn Queens
Expwy
clouddx.com 21TSXV:CDX | OTCQB:CDXFF
ADDITIONAL SLIDES
clouddx.com 22FUTU R E PROO F TSXV:CDX | OTCQB:CDXFF
THE METAVERSE
Cloud DX announces a new eXtended
Reality division to launch 3D
holographic applications for hospitals
Cloud XR’s Virtual Clinician Assistant™ offers
healthcare teams an immersive real-time
3D holographic clinical experience.
After 6 years of development Cloud DX recently
unveiled its Cloud eXtended Reality division to
support the Medical Metaverse (02/03/22). This
groundbreaking solution combines the patented,
award-winning VITALITI™ vital sign monitor with
Microsoft’s Hololens 2 or Apple’s AR application along
with additional integration to hospital record systems.
Device Agnostic Platform works in multiple AR environments.
Supported by $220,000 CAD in funding
from OCI and NSERC to date.
clouddx.com 23FUTU R E PROO F TSXV:CDX | OTCQB:CDXFF
AcuScreen™ COUGH ANALYSIS
Active tuberculosis (TB) infects over 10 million per
year and kills over 1.5 million people
CLOUD DX APPLICATION SCREENSHOTS
VITALIA® ANDROID APPLICATION – ALPHA VERSION OCTOBER 2015
The AcuScreen A.I. powered cough analysis
application is a patented, Cloud DX-developed
software platform that records and analyzes
cough sounds to detect active disease. Clinically
validated and proven 91% Accurate to detect TB.1
Aimed at replacing chest x-rays, AcuScreen
addresses a $50M available market for
primary TB screening in high-risk countries.2
AcuScreen CA™
1. Acoustic analysis of cough as a novel technology for the screening and diagnosis
of active tuberculosis; Khosa et al, Union Conf. on Lung Health, Oct 2021.
2. “Tuberculosis screening costs and cost-effectiveness in high-risk
groups: a systematic review”. BMC Inf. Dis.; Sept 2021
clouddx.com 24VA LI DATI O N TSXV:CDX | OTCQB:CDXFF
MORE PUBLISHED STUDIES & CREDIBILITY
Top North American academic institutions validate our virtual care products and services
RPM early interventions Convenience and ease of use User satisfaction is key
can improve outcomes.1,6 increase satisfaction.1,3,5,6 to RPM success.1,2,3,4,5
Virtual care improves Patient compliance RPM can lower overall
care efficiency.1,4 improves engagement.1,2,3,6 cost of care.1,4,6
1 “Post discharge after surgery virtual care with remote automated monitoring 4 “Stronger Together: Social Infrastructure for Community Health”, Ginis et al, UBC, 2021
technology” (PVC-RAM) study, McGillion et al, CMAJO March 2021 5 “Qualitative Assessment of a Non-Invasive Vital Sign Monitor with Secure Home-Based Patient
2 “Technology-Enabled Self-Management of Chronic Obstructive Engagement Platform: The e-Clinic Pilot Study” Ouellette et al, UNB, November 2015
Pulmonary Disease”, Stamenova et al, JMIR, July 2020 6 “Breathe Right at Home Project” Markham Stouffville Hospital, May 2018
3 “Evaluating the Use of Mobile Health Technology in Older Adults with * NPS = Net Promoter Score. 82 is considered “very good”.
Heart Failure”, Lefler et al, JMIR-Aging, April 2018.
clouddx.com 25VA LI DATI O N TSXV:CDX | OTCQB:CDXFF
PROVEN TO IMPROVE OUTCOMES
Prestigous 900+ patient study was recently published
in the British Medical Journal (BMJ)
n = 905 patients ‘- Standard
Cloud DX Group Outcome Improvement
ave age 63 years Care Group
Medication errors detected 30% 6% 24% more errors detected
Medication errors corrected 28% 4% 24% more errors corrected
DRIVING CHANGE
Pain experienced at day 7 59% 73% 14% reduction in reported pain
Pain experienced at day 15 48% 60% 12% reduction in reported pain Remote Monitoring
Returned to hospital* 22% 27% 5% fewer acute hospital visits
after surgery using
Cloud DX RPM is now
standard of care at
Compared to patients receiving standard post-surgical care, an eye-opening 24% Hamilton Health due to
more of Cloud DX patients were found to have medication errors, which were then this successful study.
corrected. 14% fewer Cloud DX patients reported pain vs standard care patients after
7 days at home and 5% were less likely to return to hospital over 30 days.
* in high-escalation cohort receiving RAM monitoring, McGillion et al, the BJM, Sept 2021
Note: This slide contains forward-looking statements. Please review the disclaimer on pg 2.
clouddx.com 26VA LI DATI O N TSXV:CDX | OTCQB:CDXFF
OTHER INCOME
Cloud DX earns non-dilutive funding from Government contracts, Academic Projects and Grants.
NGEN Manufacturing VITALITI™ Academic Connected Health™
Supercluster Projects Projects
Total Funding $1.75M CAD Total Funding: >$10M CAD Total Funding >$850,000
Completion date 12/31/22 Milestone dates 2022-2023 Milestone dates: 2022
Non-dilutive funding remaining: Non-dilutive funding: Non-dilutive funding:
$375,000 CAD $579,000 CAD $210,000 CAD
Total non-dilutive funding expected:
$1,164,000 CAD
Note: This slide contains forward-looking statements. Please review the disclaimer on pg 2. Funding projection at 01/01/22
clouddx.com 27W H AT W E DO TSXV:CDX | OTCQB:CDXFF
EXCLUSIVE PARTNERSHIP
7
PROVINCES
Cloud DX has been selected by Medtronic Canada ULC,
a subsidiary of Medtronic plc (NYSE:MDT | Market Cap:
13
+$150 B USD), the world’s leading medical technology HEALTH AUTHORITIES
company, to enable and support their mission of providing
world-class remote health care support. Through this
exclusive partnership, Cloud DX will provide Connected
Health™ remote patient monitoring technology and services
>1,000,000
to every sector of Medtronic’s business in Canada.
CANADIANS
clouddx.com 28W H AT W E DO TSXV:CDX | OTCQB:CDXFF
ADDITIONAL ANNOUNCEMENTS
University of Waterloo Post-Surgical Pulmonary Rehab
Nov 10 , 2 021 De c 15 , 2 021 De c 21, 2 021
Univ. of Waterloo’s Faculty of Health Cloud DX announced a new contract Cloud DX will supply Connected Health
purchased Cloud DX’s Connected Health with Hamilton Health Sciences for at-home pulmonary rehabilitation
platform to gather data at home for Surgical Transitions Program to deploy for three years, starting January 2022.
patients with neurological disorders like Connected Health to up to 2,400 post- In Ontario, 23,600 patients per year
stroke, dementia, and Parkinson’s disease. surgical patients, a direct result of the are hospitalized for COPD3 and ~78,000
successful PVC-RAM study published have post-COVID complications including
Nearly 1 in 6 people are impacted
in the British Medical Journal.2 breathing problems and fatigue.4
by neurological disorders.1
1. www.americanbrainfoundation.org/diseases; 2. Post-discharge after surgery Virtual Care with Remote Automated Monitoring-1 (PVC-RAM-1) technology versus
standard care: randomised controlled trial. BMJ Sept 30, 2021.; 3. www.cihi.ca; 4. “Rehabilitation after COVID-19”, MayoClinic.org
clouddx.com 29You can also read
